Significance of an Epidermal Growth Factor Receptor Mutation in Cerebrospinal Fluid for Carcinomatous Meningitis-Reference-Cited by-同舟云学术

Significance of an Epidermal Growth Factor Receptor Mutation in Cerebrospinal Fluid for Carcinomatous Meningitis

Published:2007 Issue:19 Volume:46 Page:1651-1655
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Kanaji Nobuhiro¹,Bandoh Shuji¹,Nagamura Norihiro¹,Kushida Yoshio²,Haba Reiji²,Ishida Toshihiko¹

Affiliation:

1. Department of Internal Medicine, Division of Endocrinology and Metabolism, Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University

2. Department of Diagnostic Pathology, Faculty of Medicine, Kagawa University

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

http://www.jstage.jst.go.jp/article/internalmedicine/46/19/46_19_1651/_pdf

Reference19 articles.

1. Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

2. Clinically Meaningful Improvement in Symptoms and Quality of Life for Patients With Non-Small-Cell Lung Cancer Receiving Gefitinib in a Randomized Controlled Trial

3. Mutations of the Epidermal Growth Factor Receptor Gene Predict Prolonged Survival After Gefitinib Treatment in Patients With Non–Small-Cell Lung Cancer With Postoperative Recurrence

4. Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysis;Heliyon;2024-05

2. Significance of an epidermal growth factor receptor mutation in cerebrospinal fluid for leptomeningeal metastasis and successful treatment with osimertinib: A case report and literature review;eNeurologicalSci;2021-03

3. Leptomeningeal Disease and the Role of Intrathecal Therapy;Central Nervous System Metastases;2020

4. Detection of EGFR, KRAS and BRAF mutations in metastatic cells from cerebrospinal fluid;Clinical Chemistry and Laboratory Medicine (CCLM);2018-04-25

5. Leptomeningeal metastasis;Handbook of Clinical Neurology;2018